Internal Server Error

Foundation Medicine - About the company

Foundation Medicine is an acquired company based in Cambridge (United States), founded in 2010 by Levi Garraway and Eric Lander. It operates as a Provider of genomics-based diagnostics test for cancer. Foundation Medicine has raised $96.5M in funding from investors like Google Ventures, Casdin Capital and Deerfield, with last known valuation of $*****. The company has 589 active competitors, including 149 funded and 123 that have exited. Its top competitors include companies like Natera, Guardant Health and Prenetics.

Company Details

Provider of genomics-based diagnostics test for cancer. The company's clinical assays, FoundationOne for solid tumors, FoundationOne Heme for hematologic malignancies and sarcomas, and the liquid biopsy test FoundationACT provide a complete genomic profile of cancers, which oncologists can use to inform their treatment decisions. In addition, all tests provide an estimate of tumor mutational burden that enables oncologists to predict immunotherapy response as well.
Social
X
Email ID
*****@foundationmedicine.com
Phone Number
+1 **********
Key Metrics
Founded Year
2010
Location
Cambridge, United States
Stage
Acquired
Total Funding
$96.5M in 4 rounds
Latest Funding Round
Last Known Valuation
$***** as on Jan 12, 2015
Ranked
Annual Revenue
$100M - $500M as on Dec 31, 2017
Employee Count
1,758 as on Aug 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by Roche (Jan 12, 2015)

Foundation Medicine's acquisition details

Foundation Medicine got acquired by Roche on Jan 12, 2015 at an acquisition amount of $*****.
Click here to take a look at Foundation Medicine's acquisition in detail
Sign up to download Foundation Medicine's company profile

Foundation Medicine's funding and investors

Foundation Medicine has raised a total funding of $96.5M over 4 rounds. Its first funding round was on Apr 15, 2010. Its latest funding round was a Series B round on Jan 08, 2013 for $*****. 1 investor participated in its latest round. Foundation Medicine has 13 institutional investors.

Here is the list of recent funding rounds of Foundation Medicine:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jan 08, 2013
1509968
Series B
3822695
1625277
6818774
1714520
Sep 20, 2012
5165456
Series B
5347293
1290579
2778126
Aug 23, 2011
2306889
Series A
9425698
8217032
lockAccess funding benchmarks and valuations. Sign up today!

Foundation Medicine's founders and board of directors

Founder? Claim Profile
The founders of Foundation Medicine are Levi Garraway and Eric Lander.
Here are the details of Foundation Medicine's key team members:

Foundation Medicine's employee count trend

Foundation Medicine has 1,758 employees as of Aug 26. Here is Foundation Medicine's employee count trend over the years:
Employee count trend for Foundation Medicine
lockUncover Foundation Medicine's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Foundation Medicine's Competitors and alternates

Top competitors of Foundation Medicine include Natera, Guardant Health and Prenetics. Here is the list of Top 10 competitors of Foundation Medicine, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Natera
Natera
2004, Redwood City (United States), Public
Developer of cell-free DNA testing for oncology, women’s health, and organ health
$152M
77/100
2nd
Logo for Guardant Health
Guardant Health
2012, Redwood City (United States), Public
Developer of digital sequencing technology for cancer detection
$557M
75/100
3rd
Logo for Foundation Medicine
Foundation Medicine
2010, Cambridge (United States), Acquired
Provider of genomics-based diagnostics test for cancer
$96.5M
70/100
4th
Logo for Prenetics
Prenetics
2009, Hong Kong (China), Public
Online platform for genetic and diagnostic health testing that helps identify health risks
$67.6M
69/100
5th
Logo for BillionToOne
BillionToOne
2015, San Francisco (United States), Public
Provider of cell-free cancer liquid biopsy test
$389M
69/100
6th
Developer of molecular diagnostics and personalized medicine for cancer
-
68/100
7th
Logo for Foresight Diagnostics
Foresight Diagnostics
2020, Aurora (United States), Acquired
Developer of minimally-invasive liquid biopsy test for the detection of cancer
$104M
66/100
8th
Logo for Caris Life Sciences
Caris Life Sciences
1996, Irving (United States), Public
Developer of panomic disease profiling technologies for cancer precision medicine
$1.23B
66/100
9th
Logo for Saga Diagnostics
Saga Diagnostics
2016, Morrisville (United States), Acquired
Provider of tests for detection and analysis of circulating tumor DNA
$17.9M
64/100
10th
Logo for Delfi Diagnostics
Delfi Diagnostics
2019, Baltimore (United States), Series B
Provider of DNA sequencing for cancer detection
$332M
63/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Foundation Medicine's competitors? Click here to see the top ones

Foundation Medicine's Investments and acquisitions

Foundation Medicine has acquired 2 companies including Saga Diagnostics and Lexent Bio. Foundation Medicine has not made any investments as of now.

Reports related to Foundation Medicine

Here is the latest report on Foundation Medicine's sector:

News related to Foundation Medicine

lockFilter this list
Media has covered Foundation Medicine for a total of 15 events in the last 1 year, 5 of them have been about company updates and 4 about partnerships.
•
Foundation Medicine acquires SAGA Diagnostics in a deal worth up to $595 millionBioStock - Connecting Innovation and•Apr 16, 2026•Saga Diagnostics, Foundation Medicine, Roche, 89bio
•
ConcertAI and Foundation Medicine Unveil Large Oncology DatasetHIT Consultant•Jan 15, 2026•Concert AI, Foundation Medicine
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Foundation Medicine

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford